CD4 and neoplasm: Studies have shown that CD73/adenosine signaling is associated with tumorigenesis and tumor progression through inhibition of CD4+T cells and NK cell proliferation, while augmenting suppressive immune subsets such as Tregs, regulatory B cells, and myeloid-derived suppressor cells (59, 60).